PRAME family pseudogene

The entry "PRAME family pseudogene" (ENSG00000251648) refers to a pseudogene associated with the PRAME (Preferentially expressed antigen in melanoma) gene family. Pseudogenes do not encode functional proteins and are not involved in canonical biological pathways, disease processes, or therapeutic targeting. The functional PRAME gene is a cancer/testis antigen and a clinically studied biomarker and immunotherapeutic target, but pseudogenes in this family do not possess these properties. Information commonly associated with drug targets (structure, functions, disease roles, interacting drugs, etc.) is generally not available or applicable for pseudogenes[5][7]. Essential context supporting this assessment: - Pseudogenes are genomic DNA sequences similar to normal genes but non-functional; they are typically considered "defunct" relatives of functional genes[5]. - The PRAME gene (canonical: Preferentially expressed antigen in melanoma) is indeed a therapeutic target in oncology—characterized as a member of the cancer/testis antigen family with relevance to leukemia, melanoma, and other cancers[1][2][7]. However, pseudogenes in this family, including any designated "PRAME family pseudogene," lack established protein-coding function and are not therapeutically targeted or studied as biomarkers[5][7]. - Ensembl gene ID ENSG00000251648 reflects a pseudogene; these are typically not named with functional molecular classifications (such as receptor, enzyme, channel, or transcription factor) and have no drug interactors, mechanism of action, or disease association[5][7]. - If the intended query was to retrieve information about PRAME as a functional target, please clarify, as that would return information on a well-established cancer/testis antigen and immunotherapy target[1][2][7]. In summary, "PRAME family pseudogene" (ENSG00000251648) is not a drug target. It is a non-coding, non-functional genomic element deriving from the PRAME gene family, and so most of the structured target attributes are not relevant.